Skip to content

Comparison of septoplasty with or without turbinoplasty on the symptom profile in patients with deviated nasal septum and inferior turbinate hypertrophy

A comparative study on effect of septoplasty with or without turbinoplasty on the symptom profile in patients with DNS and inferior turbinate hypertrophy - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/100202
Enrollment
100
Registered
2026-01-02
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J342- Deviated nasal septum Health Condition 2: J343- Hypertrophy of nasal turbinates

Interventions

Intervention1: Septoplasty with turbinoplasty: In patients with deviated nasal septum and inferior turbinate hypertrophy both septoplasty and turbinoplasty is done Control Intervention1: Septoplasty w

Sponsors

Dr Arunabha Sengupta
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Having persistent moderate to severe nasal obstruction due to DNS with contralateral hypertrophied inferior turbinate(grades 2 and 3) wil be included.

Exclusion criteria

Exclusion criteria: 1.Patients with drug allergies and known end organ damage i.e. cerebrovascular diseases, cardiovascular system disorder, Hypertension, asthma or chronic obstructive lung disease, diabetes mellitus, coagulation defect, hepatic or renal failure, malignancy and other debilitating diseases. 2.Age less than 18 years and more than 60 years 3.Patients having craniofacial malformation. 4.Patients having any cause of bilateral inferior turbinate hypertrophy like sinonasal polyposis, allergic rhinitis, sinusitis, chronic hypertrophic rhinitis, septal perforation. 5.Patients who had previous nose surgery were excluded from the study. 6.Patient not willing to participate. 7.Patient unfit for surgery or anaesthesia.

Design outcomes

Primary

MeasureTime frame
Comparison of symptom improvementTimepoint: 3 and 6 months

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactArunabha Sengupta

Institute of Post Graduate Medical Education and Research & Seth Sukhlal Karnani Memorial Hospital

arunabhasengupta2008@gmail.com9831089737

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026